Neoadjuvant Chemotherapy and Radiation for Patients with Locally Unresectable Pancreatic Adenocarcinoma: Feasibility, Efficacy, and Survival
- 1 January 2008
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 12 (1) , 91-100
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative TherapyAnnals of Surgical Oncology, 2006
- Current therapies and advances in the treatment of pancreatic cancerCritical Reviews in Oncology/Hematology, 2006
- Survival Among Patients with Adenocarcinoma of the Pancreas: A Population-based Study (United States)Cancer Causes & Control, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Cytotoxic Chemotherapy for Pancreatic CancerDrugs, 2006
- The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTXSurgical Oncology Clinics of North America, 2004
- Inflammatory Breast Carcinoma: The Sphinx of Breast Cancer ResearchJournal of Clinical Oncology, 2004
- Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreasJournal of Gastrointestinal Surgery, 2003
- Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancerJournal of Surgical Oncology, 2002
- The role of laparoscopy in the management of suspected pancreatic and periampullary malignanciesJournal of Gastrointestinal Surgery, 1997